The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 13, 2021

Filed:

Feb. 24, 2016
Applicant:

Scandion Oncology A/s, Copenhagen, DK;

Inventors:

Steffen Rump, Hannover, DE;

Henning Weigt, Isernhagen, DE;

Assignee:

Scandion Oncology A/S, Copenhagen, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/15 (2006.01); A61K 31/519 (2006.01); A61K 31/565 (2006.01); A61K 31/566 (2006.01); A61K 31/5685 (2006.01); A61K 45/06 (2006.01); C07D 487/04 (2006.01); A61K 31/015 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/015 (2013.01); A61K 31/519 (2013.01); A61K 31/565 (2013.01); A61K 31/566 (2013.01); A61K 31/5685 (2013.01); A61K 45/06 (2013.01);
Abstract

The present invention relates to 5-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives of the general formula (I) or pharmaceutically acceptable salts or propharmacons thereof for use as BCRP inhibitors, wherein at least one hydrogen atom in at least one of the phenyl groups A and B is substituted by a substituent R, which has a Hammett constant σgreater than 0.23. For corresponding compounds, surprisingly a particularly high inhibitory activity against BCRP has been discovered which can be exploited for suppressing the multidrug resistance modulator BCRP, thus providing an improvement in efficacy of BCRP affected drugs. This has useful implications for cancer and HIV treatment.


Find Patent Forward Citations

Loading…